Preclinical data of rabbits having convulsions has prompted the U.S. FDA to place a clinical hold on Neumora Therapeutics Inc.’s phase I study of NMRA-266 in healthy adults. Neumora said about 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback